{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:01Z","timestamp":1786119541114,"version":"build-2736575974"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/wnf.0b013e3181e1613f","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:29:58Z","timestamp":1280179798000},"page":"216-217","source":"Crossref","is-referenced-by-count":15,"title":["Posthypoxic Myoclonus (Lance-Adams Syndrome) Treated With Lacosamide"],"prefix":"10.1097","volume":"33","author":[{"given":"Norbert","family":"Galldiks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gereon Rudolf","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Burghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870150702","article-title":"The clinical spectrum of posthypoxic myoclonus.","volume":"15","author":"Frucht","year":"2000","journal-title":"Mov Disord"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","article-title":"Myoclonus: current concepts and recent advances.","volume":"3","author":"Caviness","year":"2004","journal-title":"Lancet Neurol"},{"key":"R3-14-20210203","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.57.6.1112","article-title":"A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.","volume":"57","author":"Frucht","year":"2001","journal-title":"Neurology"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.wnf.0000265978.72772.2d","article-title":"Dramatic effect of levetiracetam on posthypoxic myoclonus: difficult weaning from mechanical ventilation.","volume":"32","author":"Muslu","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"R5-14-20210203","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0310057X0903700214","article-title":"A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate.","volume":"37","author":"Arpesella","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"R6-14-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14737175.9.1.33","article-title":"Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.","volume":"9","author":"Beydoun","year":"2009","journal-title":"Expert Rev Neurother"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181e1613f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:32:46Z","timestamp":1786041166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201007000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181e1613f","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}